Reviewing Preliminary Results from a First-in-Human Trial with MORAb-202

Time: 4:30 pm
day: day 2- pm

Details:

  • Providing a background on MORAb-202
  • Sharing preliminary safety and efficacy of MORAb-202 in first-in-human studies
  • Detailing information on pharmacokinetics of MORAb-202

Speakers: